OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2021-12-31-accounts

Charity number: 1003619 Company number: 2626039

THE BLOOD CARE FOUNDATION

TRUSTEES’ REPORT AND UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2021

THE BLOOD CARE FOUNDATION

(A company limited by guarantee)

CONTENTS

Legal and Administrative information 1
Report of the Trustees 2 - 7
Independent Examiner’s Report 8
Statement of Financial Activities 9
Balance Sheet 10
Notes to the Financial Statements 11 - 16

Detailed income and expenditure account and summaries

THE BLOOD CARE FOUNDATION (A company limited by guarantee)

LEGAL AND ADMINISTRATIVE INFORMATION FOR THE YEAR ENDED 31 DECEMBER 2021

Trustees Mr J. Bruce, Chairman
Mr M.G. Bruce, Chairman Emeritas
Dr J. Barrett
Dr R.M. Dawood
Dr C.P. Lee O.St.J
Mr B.J. Pearson
Col. M.J.G. Thomas
Company registered number 2626039
Charity registered number 1003619
Registered office North House
198 High Street
Tonbridge
Kent
TN9 1BE
Company secretary M.F. Gunton
Chief executive officer J.N. Bruce
Independent examiner A.S. Healey FCA CTA DChA
Lindeyer Francis Ferguson Limited
Chartered Accountants
North House
198 High Street
Tonbridge
Kent
TN9 1BE
Bankers The Royal Bank of Scotland
London Drummonds Branch
49 Charing Cross
London
SW1A 2DX

Page 1

THE BLOOD CARE FOUNDATION

(A company limited by guarantee)

TRUSTEES’ REPORT FOR THE YEAR ENDED 31 DECEMBER 2021

The Trustees (who are also directors of the charity for the purposes of the Companies Act) present their annual report together with the financial statements of The Blood Care Foundation (the company) for the year ended 31 December 2021.

The Trustees confirm that the report and financial statements of the charity comply with the current statutory requirements, the requirements of the company's governing document, and the provisions of "Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)" (effective 1 January 2019) (Charities SORP (FRS 102)). The Legal and Administrative information on page 1 forms part of this report.

Structure, governance and management

a. Constitution

The company is registered as a charitable company limited by guarantee incorporated on 2 July 1991 and governed by a Memorandum and Articles of Association, as revised on 24 April 2013.

The principal object of the company continued to be the supply and distribution of screened blood, resuscitation fluids and sterile transfusion equipment.

In setting objectives and planning for activities, the Trustees have given due consideration to general guidance published by the Charity Commission relating to public benefit.

b. Method of appointment or election of Trustees

Potential new trustees are usually identified by the directors as being suitable candidates to approach. If that person is prepared to consider such an appointment and they have the required ability and commitment, they are invited to join the Foundation. The new trustee is invited to sign a letter of application, following which they are elected to the board.

Appointments made during the year are ratified at the following AGM. Given the size of the charity, there are no formal policies in place for the induction and training of Trustees. However, each trustee, from their own knowledge and experience, is aware of their responsibilities and is required to keep up to date through technical reading and personal development.

c. Organisational structure and decision making

The Foundation is run by its directors who are also the Trustees of the charity and members of the company. The Trustees bring a broad range of knowledge to the Foundation and, under the chairmanship of Julian Bruce, are responsible for managing the current activities of the Foundation and developing its future plans.

Page 2

THE BLOOD CARE FOUNDATION

(A company limited by guarantee)

TRUSTEES’ REPORT FOR THE YEAR ENDED 31 DECEMBER 2021

Members' liability

The members of the company guarantee to contribute an amount not exceeding £1 to the assets of the charity in the event of winding up.

Review of activities for the public benefit and future developments

The Trustees recognise and confirm their awareness of the need for the activities of the Foundation to be for the public benefit.

When the Foundation was first established, its aims and objectives were based on the principle that each country should, in an emergency, be responsible for the provision of blood at an acceptable quality, for its own nationals.

From its inception, the Foundation has been making and continues to make part of its practical contributions to this principle through the training of blood banking staff and by providing a consultancy service in Transfusion Medicine to treating doctors.

Each time the BCF Quality Assurance Manager audits one of its own, or another organisation's dedicated blood banks in a developing country, time is taken to train the local blood bankers in the latest techniques of blood banking, to help increase their own knowledge and contribute to the overall development of blood banking standards in that particular country.

As in-depth Transfusion Medicine does not normally form part of the standard medical training in many countries, the Foundation provides a world-wide consultancy support service to treating doctors when they are faced with difficult transfusion decisions.

Chairman’s Report

The Need for Blood and Rabies Immunoglobulin, their Availability and Quality

The continuing restrictions on travel during 2021 resulted in a further year where demands for the Foundation’s services were fewer than before the pandemic set in.

However, those companies which maintained their expatriate staff in developing countries continued to benefit from the protection offered by their Blood Care Programme membership. This was especially important in those regions suffering from civil unrest as well as their ongoing exposure to the risks of accidents, illnesses prevalent in their parts of the world and, of course, the dangers to life from a rabies infection.

Blood

On behalf of the Trustees, I should like to express our sincere gratitude to the internationally recognised Transfusion Centres from which the Foundation has sourced its blood supplies throughout the year. Despite these Centres experiencing their own considerable shortages due to the greatly reduced number of blood

Page 3

THE BLOOD CARE FOUNDATION (A company limited by guarantee)

TRUSTEES’ REPORT FOR THE YEAR ENDED 31 DECEMBER 2021

donors, their reduced but invaluable support for the Foundation and its objectives has enabled it to continue to protect those facing an emergency.

Rabies

The challenge of being able to react swiftly when someone is exposed to the risk of developing rabies is an ongoing one. The Foundations stock of rabies immunoglobulin allowed its potential life-saving service to be maintained during the year, thereby giving considerable peace of mind to Blood Care Programme members, particularly to those located throughout the developing world where the threat of contracting the disease is particularly high.

Consultancy Services

The Foundation’s support service offered to medical staff treating members is gratefully appreciated in those instances where they are faced with difficult situations, enabling them to benefit from current transfusion knowledge or treatment of suspected cases of rabies contamination.

Alarm Centre

The ability to contact the Foundation at any time is an essential part of its service and can prove to be lifesaving as well as giving great comfort and support to the patient, their family and their treating doctor in times of an emergency.

Website

The website was updated during the year allowing simple access to the Foundations history and organisation as well as enabling individuals to enrol easily in its Blood Care Programme.

Quality

Since its formation in 1991, the Foundation has made the quality of its blood products and the rabies treatment it provides, as well as its services, the number one priority. This has been and continues to be absolutely critical in all cases, especially in those areas where the processing, storage of blood and vital rabies treatment at acceptable standards are essential for human use.

As the maintenance of these standards is far from easy, the Foundation benefits from the support offered by:

Page 4

THE BLOOD CARE FOUNDATION (A company limited by guarantee)

TRUSTEES’ REPORT FOR THE YEAR ENDED 31 DECEMBER 2021

Finance

Despite the continuing negative effects of Covid-19 and its derivatives during the year, the Foundation succeeded in balancing its accounts, albeit with a reduced income, notably from the reduction in its membership renewal fees and the absence of income from the BCF Travel Club. The variable fees received for Special Projects such as specific blood deliveries to hospitals and UN operations were modestly reduced and no donations were received in 2021. In total, the Foundation received a gross income of £223,871, resulting in a net income of £400.

There was no movement in the ring-fenced Fund for Projects during the year and, at the end of 2021 this Fund stood at £146,588 and the Foundation had net assets of £162,682.

The charity aims to slowly build up the level of reserves for operational purposes whilst maintaining designated funds which are built up from special receipts (such as legacies) and which will be used to fund special projects.

Membership

The severe restrictions on the ability to travel throughout the year resulted in a second year where sales of membership of the Blood Care Programme were unable to continue.

Despite this on-going downturn in business, existing memberships held by expatriates and their families, located primarily in the developing world were maintained, as the risks to their health and well-being remained at a high level in many locations. This was particularly important as the blood available for transfusions in an emergency became even more scarce and the risk from rabies remained at a high level.

Management

I should like to pay tribute to the Foundation’s very experienced board of Trustees, its Advisory Council and External Audit panel, who provide advice and counsel on the latest developments in blood transfusion, the risk of rabies, accountancy and the law, for their continued invaluable support of its management team throughout the year.

Conclusion

Although, like many other charities and commercial organisations, the past two years have been extremely difficult, the Trustees are optimistic the relaxation of many travel restrictions planned for 2022 will enable

Page 5

THE BLOOD CARE FOUNDATION (A company limited by guarantee)

TRUSTEES’ REPORT FOR THE YEAR ENDED 31 DECEMBER 2021

the Foundation to continue its development and meet its objectives of providing its frequently life-saving services on an increasing greater scale.

Relationship with other organisations

The Foundation has a relationship with Asclepius (International) Limited. This company, which is beneficially owned by members of the Bruce family, is a UK based organisation active in the fields of expatriate health and general medical services. Asclepius provides the Foundation with the clinical and general management services, quality assurance, legal and administrative services which are vital to the operations of the charity. Although the Foundation can provide these services itself, they have been outsourced to protect the Foundation, by enabling it to operate with the minimum level of overheads. Asclepius has been instrumental in its formation and has contributed to its development by charging less than the full fees payable by the Foundation (see note 11).

Asclepius arranges the recruitment of administrative staff for the Foundation and pays their fees or salaries. The objective of this arrangement is to protect the Foundation, so that if its income fell for any reason, the Foundation would not be left with an unsustainable overhead to carry.

Trustees' responsibilities statement

The Trustees (who are also directors of The Blood Care Foundation for the purposes of company law) are responsible for preparing the Trustees' Report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice), including the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102).

Company law requires the Trustees to prepare financial statements for each financial year. Under company law the Trustees must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the charitable company and of the incoming resources and application of resources, including the income and expenditure, of the charitable company for that period. In preparing these financial statements, the Trustees are required to:

The Trustees are responsible for keeping adequate accounting records that are sufficient to show and explain the charitable company's transactions and disclose with reasonable accuracy at any time the financial position of the charitable company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the charitable company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Page 6

THE BLOOD CARE FOUNDATION

(A company limited by guarantee)

TRUSTEES’ REPORT FOR THE YEAR ENDED 31 DECEMBER 2021

This report has been prepared in accordance with the provisions applicable to small companies subject to the small companies’ regime in Part 15 of the Companies Act 2006

This report was approved by the Trustees on 27 June 2022 and signed on their behalf by:

Michael G. Bruce, Chairman Emeritus & Trustee

Page 7

THE BLOOD CARE FOUNDATION (A company limited by guarantee)

INDEPENDENT EXAMINER’S REPORT FOR THE YEAR ENDED 31 DECEMBER 2021

I report to the charity trustees on my examination of the accounts of the company for the year ended 31 December 2021.

Responsibilities and basis of report

As the trustees of the company (and its directors for the purposes of company law) you are responsible for the preparation of the accounts in accordance with the requirements of the Companies Act 2006 (‘the 2006 Act’).

Having satisfied myself that the accounts of the company are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of the company’s accounts carried out under section 145 of the Charities Act 2011 (‘the 2011 Act’). In carrying out my examination I have followed the Directions given by the Charity Commission under section 145(5)(b) of the 2011 Act.

Independent examiner's statement

I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe:

In my opinion, in order to enable a proper understanding of the accounts to be reached, attention should be drawn to the disclosures made in Note 2.1 to the financial statements concerning the accounting treatment of a liability disclosed as a contingent liability.

Amy Healey FCA CTA DChA Dated: 13 July 2022 Lindeyer Francis Ferguson Limited

Chartered Accountants North House 198 High Street Tonbridge Kent TN9 1BE

Page 8

THE BLOOD CARE FOUNDATION

(A company limited by guarantee)

STATEMENT OF FINANCIAL ACTIVITIES (incorporating income and expenditure account) FOR THE YEAR ENDED 31 DECEMBER 2021

Notes
Income from:
Donations and legacies
Charitable activities
3
Investments
Total income
Expenditure on:
Charitable activities
4
Total expenditure
Net income and net movement in funds
Reconciliation of funds:
Total funds brought forward
Total funds carried forward
10		 Unrestricted
funds
2021
£
34
223,826
11
223,871
223,471
223,471
400
162,282
162,682		 Unrestricted
funds
2020
£
20,270
266,194
549
287,013
269,138
269,138
17,875
144,407
162,282

Page 9

THE BLOOD CARE FOUNDATION

(A company limited by guarantee)

BALANCE SHEET AS AT 31 DECEMBER 2021

Notes
Current assets
Debtors
8
Cash at bank and in hand
Creditors: amounts falling due
within one year
9
Net current assets
Net assets
The funds of the charity
Unrestricted funds
10		 £
80,869
139,023
219,892
( 57,210)		 2021
£
162,682
162,682
162,682		 £
82,075
158,555
240,630
( 78,348)		 2020
£
162,282
162,282
162,282

For the financial year ended 31 December 2021 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies' regime.

The financial statements were approved by the Trustees on 27 June 2022 and signed on their behalf by:

Michael G. Bruce, Chairman Emeritus & Trustee

Company Registration Number: 2626039

Page 10

THE BLOOD CARE FOUNDATION

(A company limited by guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2021

1 Status

The Blood Care Foundation is a private charitable company limited by guarantee incorporated in England & Wales. Its registered address is North House, 198 High Street, Tonbridge, Kent, TN9 1BE.

2 Accounting policies

The principal accounting policies adopted, judgements and key sources of estimation uncertainty in the preparation of the financial statements are as follows:

2.1 Basis of preparation

The financial statements have been prepared in accordance with "Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)" (effective 1 January 2019) - (Charities SORP (FRS 102)), the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) and the Companies Act 2006.

The trustees have concluded that the financial statements give a true and fair view of the charity’s financial position and financial performance. The charity has complied with FRS 102 except that it has departed from Section 21 ‘Provisions and Contingencies’ to the extent necessary to give a true and fair view. The charity has accounted for a contingent liability of £216,499 at the balance sheet date, as shown in note 11. Section 21 of FRS 102 requires recognition of a provision in the balance sheet where it is probable that the obligation will be repaid but the timing or amount is uncertain. In recent years there has been a partial repayment of the amount due which makes it probable that some or all of the debt will be repaid. However the trustees consider that to include a provision in the accounts would not present a true and fair view. The charity is only required to repay the balance out of future income in such manner as the trustees consider appropriate, taking into account the charity’s resources. In the event of the charity winding up the amount due would be waived. The Trustees therefore consider that disclosure of a contingent liability gives a true and fair view.

The accounts are presented in pounds sterling and rounded to the nearest pound.

The Blood Care Foundation meets the definition of a public benefit entity under FRS 102. Assets and liabilities are initially recognised at historical cost or transaction value unless otherwise stated in the relevant accounting policy notes.

There are no material uncertainties about the charity's ability to continue, and so the going concern basis of accounting has been adopted.

Page 11

THE BLOOD CARE FOUNDATION

(A company limited by guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2021

2 Accounting policies (continued)

2.2 Income

Total income comprises the invoiced value of membership fees, other services supplied to third parties and interest received. Income from membership fees is recognised over the period covered by the membership subscription on a straight-line basis. Income from other services is recognised in the period when the service is performed. Interest is recognised in the period to which it relates.

Income from legacies is recognised at the earlier of receipt of the legacy or the date of approval for distribution.

2.3 Expenditure and liabilities

Liabilities, and related expenditure, are recognised when a present legal or constructive obligation exists at the balance sheet date as a result of a past event, it is probable that a transfer of economic benefits will be required to settle the obligation, and the amount can be measured or estimated reliably.

Charitable activities includes expenditure on the supply and distribution of blood and equipment. It includes both costs that can be allocated directly to such activities and those costs of an indirect nature necessary to support them including governance costs incurred in connection with administration of the company and compliance with constitutional and statutory requirements.

2.4 Financial instruments

The charity only has financial instruments of a kind that qualify as basic financial instruments. Basic financial instruments are initially recognised at transaction value and subsequently measured at their settlement value.

2.5 Foreign currencies

Monetary assets and Iiabilities denominated in foreign currencies are translated into sterling at rates of exchange ruling at the balance sheet date.

Transactions in foreign currencies are translated into sterling at the rate ruling on the date of the transaction.

Exchange gains and losses are recognised in the Statement of Financial Activities.

Page 12

THE BLOOD CARE FOUNDATION

(A company limited by guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2021

3 Income from charitable activities

Membership fees
Special project fees
4
Expenditure on charitable activities
Direct costs
Blood supplies and testing
Transport and shipping
Clinical and quality assurance
Service fees
Support costs
Administration and support fees
Alarm centre
Telephone and fax
Printing and stationery
Postage
Travel and subsistence
Rent and rates
Exchange differences
Other office costs
Legal and professional fees
Marketing and promotion
Governance costs
Independent Examiners' remuneration
Independent Examiners' other services		 2021
£
71,725
152,101
223,826
2021
£
102,586
14,931
44,800
36,690
7,173
2,448
1,522
375
533
-
4,224
( 1,484)
5,620
487
-
2,266
1,300
223,471		 2020
£
107,737
158,457
266,194
2020
£
117,809
14,428
44,865
59,095
10,773
2,560
678
409
468
459
4,224
5,103
6,595
356
( 2,500)
2,516
1,300
269,138

5 Turnover 75.38% of the charity's income (2020 - 74.01%) is attributable to geographical markets outside the United Kingdom.

Page 13

THE BLOOD CARE FOUNDATION

(A company limited by guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2021

6 Net income

Net income
This is stated after charging:
Independent Examiners' remuneration
Independent Examiners' other services		 2021
£
2,266
1,300
3,566		 2020
£
2,516
1,300
3,816

7 Trustees' remuneration and expenses

Key management personnel are defined as the Trustees only. During the year, no Trustees received any remuneration or benefits in kind for their services as trustees (2020 - £nil). Col. M.J.G. Thomas, trustee, received fees of £41,296 for clinical and quality assurance services provided in the year (2020: £41,296).

None of the trustees were reimbursed for expenses during the year. In 2020 no trustees were reimbursed for expenses.

8 Debtors

Fees receivable
Deferred expenditure		 2021
£
76,035
4,834
80,869		 2020
£
77,086
4,989
82,075

Page 14

THE BLOOD CARE FOUNDATION

(A company limited by guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2021

9 Creditors: amounts falling due within one year

Trade creditors
Accruals and deferred income
Fees invoiced in advance included in deferred income
Balance at 1 January 2021
New amounts invoiced
Amounts released to income for services rendered
Balance at 31 December 2021		 2021
£
37,375
19,835
57,210
£
9,978
9,668
( 9,978)
9,668		 2020
£
60,573
17,775
78,348
£
28,721
9,978
( 28,721)
9,978

10 Movement in funds

Current year
Unrestricted funds
General fund
Designated funds:
Fund For Projects		 Brought
forward
15,694
146,588
162,282		 Income
223,871
-
223,871		 ( 223,471)
-
( 223,471)
Expenditure		 Carried
forward
16,094
146,588
162,682

The designated fund was created to fund special projects following the receipt of legacy income in prior years. The trustees have decided that the funds should be designated for a marketing programme and for other special, designated projects, bearing the name of the donor where appropriate.

Prior year
Unrestricted funds
General fund
Designated funds:
Fund For Projects		 Brought
forward
15,589
128,818
144,407		 Income
269,243
17,770
287,013		 Expenditure
( 269,138)
-
( 269,138)		 Carried
forward
15,694
146,588
162,282

Page 15

THE BLOOD CARE FOUNDATION

(A company limited by guarantee)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2021

11 Contingent assets and liabilities

Contingent liability

A contingent liability exists towards Asclepius (International) Limited, which has charged less than the full fees payable by The Blood Care Foundation for services provided. This contingent liability amounts to £216,449 at 31 December 2021 (2020: £224,449) and is only payable in the future out of surplus income (if any) at such time and in such manner as the Trustees shall consider appropriate.

12 Related party transactions

Asclepius (International) Limited is a supporter of the objectives of the Blood Care Foundation having been responsible for its formation. It is beneficially owned by members of the Chairman's family and provides management, clinical, quality assurance, legal and administrative services to the Foundation.

2021 2020
£ £
Service fees, management and administrative services 43,863 69,868
Clinical and quality assurance costs 41,296 41,296
Office rent 4,224 4,224

At the balance sheet date £24,589 (2020: £34,416) was due to Asclepius (International) Limited and this is included in creditors.

Page 16